Precision NanoSystems

Precision NanoSystems Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was co-founded by Pieter Cullis, who also co-founded Acuitas Therapeutics.¹⁾ His co-founders are Euan Ramsay and James Taylor.

The company develops genetic medicine-based therapies, including “self-assembling” molecules that carry drugs and gene therapies directly into the cells of the human body using DNA and RNA encapsulated in lipid nanoparticles.^{2) 3)} It was launched with assistance from Genome British Columbia.⁴⁾

Precision NanoSystems was founded in 2010 by Pieter Cullis, Euan Ramsay and James Taylor.^{5) 6)}

On October 23, 2020, Prime Minister Justin Trudeau announced that he had awarded the company $18.2 million from the Government of Canada to develop an RNA vaccine for COVID-19.⁷⁾ The funding came from Innovation, Science and Economic Development Canada’s Strategic Innovation Fund (SIF), which focuses on supporting private sector-led vaccine and therapy clinical trials.

The company was acquired by Danaher on June 1, 2021.⁸⁾

In July 2022, Replicate Bioscience issued a press release announcing a partnership with Precision NanoSystems to “accelerate the creation, scale-up, and delivery of self-replicating RNA (srRNA) therapies.”⁹⁾

Investors in Precision NanoSystems include:¹⁰⁾

• 5AM Ventures
• Accel-Rx
• Northview LifeSciences
• Rising Tide
• Telegraph Hill Partners

• White Rose Wiki